Clinical Trial Update: Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of the GnRH analogue triptorelin for reducing HIV-1 reservoirs in ART-treated patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Triptorelin (triptorelin)

Snippet

Sponsor: Immune System Regulation AB | Conditions: HIV-1-infection | Phase 2 | Status: UNKNOWN